FMII
AXSM icon

Farmers & Merchants Investments Inc’s Axsome Therapeutics AXSM Stock Holding History

Farmers & Merchants Investments Inc’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-102
Closed -$4K – 1562
2022
Q2 		$4K Hold
102
– – ﹤0.01% 873
2022
Q1 		$4K Hold
102
– – ﹤0.01% 892
2021
Q4 		$4K Sell
102
-39
-28% -$1.44K ﹤0.01% 906
2021
Q3 		$5K Sell
141
-4
-3% -$156 ﹤0.01% 842
2021
Q2 		$10K Buy
145
+29
+25% +$1.74K ﹤0.01% 644
2021
Q1 		$7K Buy
+116
New +$8.16K ﹤0.01% 695

Other funds holding AXSM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
ACM
Alethea Capital Management Mercer Island, Washington $195M AUM 51.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Farmers & Merchants Investments Inc's AXSM Position: Q3 2022 in Review

Farmers & Merchants Investments Inc sold out of Axsome Therapeutics (AXSM) in Q3 2022, closing a stake of 102 shares — an estimated $4K sold.

Farmers & Merchants Investments Inc first reported a position in AXSM in Q1 2021 and held it in 6 quarters. The position peaked at $10K in Q2 2021. 189 funds tracked by Wall St. Rank hold AXSM as of Q3 2022.

  • Farmers & Merchants Investments Inc reported no remaining Axsome Therapeutics position as of Q3 2022 after selling out during the quarter.
  • Farmers & Merchants Investments Inc sold 102 Axsome Therapeutics shares in Q3 2022, an estimated $4K.
  • Farmers & Merchants Investments Inc first reported a position in Axsome Therapeutics in Q1 2021 and held it in 6 quarters.
  • Farmers & Merchants Investments Inc's Axsome Therapeutics position peaked at $10K in Q2 2021.
  • 189 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q3 2022.

Based on Farmers & Merchants Investments Inc's 13F filing for Q3 2022, filed 31 Oct 2022.